Skip to content
2000
Volume 18, Issue 22
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

MicroRNAs (miRNAs) are significant regulators of human hematopoietic stem cells (HSC), and their deregulation contributes to hematological malignancies. Myelodysplastic syndromes (MDS) represent a spectrum of hematological disorders characterized by dysfunctional HSC, ineffective blood cell production, progressive marrow failure, and an increased risk of developing acute myeloid leukemia (AML). Although miRNAs have been primarily studied in AML, only recently have similar studies been performed on MDS. In this review, we describe the normal function and expression of miRNAs in human HSC, and describe mounting evidence that deregulation of miRNAs contributes to the pathogenesis of MDS.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612811209023170
2012-07-01
2025-05-09
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612811209023170
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test